Solid Malignancy

• CLINICAL_TRIALS research · 2026-01-28
  Clinical Trial Update: EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) [Phase 1, Phase 2]

  EMITT-1 is a Phase 1/2 clinical trial by Grey Wolf Therapeutics evaluating ERAP-mediated immunopeptidome targeting for advanced solid malign…

• CLINICAL_TRIALS trial_result · 2024-01-11
  Clinical Trial Update: Romiplostim in Chemotherapy-Induced Thrombocytopenia [Phase 3]

  Phase 3 clinical trial update for romiplostim in chemotherapy-induced thrombocytopenia associated with solid malignancies.